Detalhe da pesquisa
1.
Women's motivations for participating in the dapivirine vaginal ring open label extension study.
AIDS Care
; 36(3): 326-342, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734338
2.
Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex.
AIDS Care
; 36(1): 80-86, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37066990
3.
Experience with Contraceptive Dosage Forms and Interest in Novel PrEP Technologies in Women.
AIDS Behav
; 27(11): 3596-3602, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221330
4.
Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial.
AIDS Behav
; 27(3): 1030-1043, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066762
5.
Integrating Gender-Based Violence Screening and Support into the Research Clinic Setting: Experiences from an HIV Prevention Open-Label Extension Trial in Sub-Saharan Africa.
AIDS Behav
; 27(4): 1277-1286, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36178556
6.
Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa.
BMC Public Health
; 23(1): 1210, 2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349816
7.
Key stakeholders' perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South Africa.
Afr J AIDS Res
; 22(1): 18-26, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951406
8.
Genital Immune Cell Activation and Tenofovir Gel Efficacy: A Case-Control Study.
Clin Infect Dis
; 75(6): 1088-1091, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35142337
9.
Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical Trial.
AIDS Behav
; 26(8): 2623-2631, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35122575
10.
Ring-ing in the Future: Participant and Male Partner Perspectives Regarding Future Use of the Dapivirine Vaginal Ring for HIV Prevention.
AIDS Behav
; 26(6): 1923-1932, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064389
11.
Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial.
AIDS Behav
; 26(5): 1597-1606, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34727272
12.
Exploring the Use of Oral Pre-exposure Prophylaxis (PrEP) Among Women from Durban, South Africa as Part of the HIV Prevention Package in a Clinical Trial.
AIDS Behav
; 25(4): 1112-1119, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106996
13.
Using Emoji Stickers to Understand End-User Opinions of the Dapivirine Vaginal Ring for HIV Prevention.
AIDS Behav
; 25(12): 3955-3966, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34180041
14.
Men's Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe.
AIDS Behav
; 25(6): 1890-1900, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33389318
15.
Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention.
AIDS Behav
; 25(9): 2801-2814, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117592
16.
The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence.
AIDS Behav
; 25(12): 4169-4179, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33939034
17.
Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study.
BMC Public Health
; 21(1): 2041, 2021 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34749675
18.
Importance of early identification of PrEP breakthrough infections in a generalized HIV epidemic: a case report from a PrEP demonstration project in South Africa.
BMC Infect Dis
; 20(1): 532, 2020 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32698772
19.
Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection.
N Engl J Med
; 373(6): 530-9, 2015 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26244306
20.
Cervicovaginal Inflammation Facilitates Acquisition of Less Infectious HIV Variants.
Clin Infect Dis
; 64(1): 79-82, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27694480